Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
M6P Therapeutics logo — Next generation enzyme replacement and gene therapies for ra...

M6P Therapeutics

Next generation enzyme replacement and gene therapies for rare diseases.

Founded 2017 United States United States 20 employees Biopharma, Biotechnology +2

General Information

Company Name M6P Therapeutics
Founded Year 2017
Location United States United States +1
Employees 20
Industries Biopharma, Biotechnology, Health Care +1
Social

Get notified when M6P Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About M6P Therapeutics

M6P Therapeutics is a biotech startup founded in 2017, with a focus on developing next-generation enzyme replacement and gene therapies for lysosomal storage disorders. Their slogan "Next generation enzyme replacement and gene therapies for rare diseases" encapsulates their mission. The company has made significant strides in discovering a novel method for enhancing the mannose-6-phosphate phosphorylation of various lysosomal enzymes, leading to improved enzyme delivery to target tissues. This breakthrough technology holds promise for enhancing clinical outcomes in the treatment of rare diseases. M6P Therapeutics operates in the Biopharma, Biotechnology, Health Care, and Life Sciences industries, indicating a broad scope of potential impact in the medical field. Despite not having specific details on their headquarters or the latest investment, M6P Therapeutics' innovative approach positions them as an intriguing prospect for potential venture capital investment.

Taxonomy: enzyme replacement therapy, gene therapy, lysosomal storage disorders, rare diseases, clinical research, novel therapies, M6P phosphorylation, enzyme delivery, research solutions, biotechnology advances, lysosomal storage diseases

No funding data available for M6P Therapeutics yet.

Get notified when M6P Therapeutics raises funding

M6P Therapeutics Alternatives & Competitors

M6P Therapeutics vs
Zystor
Zystor

A privately-held biotechnology company pioneering enzyme replacement therapies to treat lysosomal st...

Series A
Biotechnology, Health Care
M6P Therapeutics vs
Lysoway Therapeutics
Lysoway Therapeutics United States

Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic...

Grant
7 employees
Biotechnology, Health and Wellness
M6P Therapeutics vs
Orphazyme
Orphazyme

Pioneering therapies to address severe lysosomal storage disorders with roots in groundbreaking acad...

Post Ipo Equity
Biotechnology, Health Care

FAQ About M6P Therapeutics

Next generation enzyme replacement and gene therapies for rare diseases.
M6P Therapeutics was founded in 2017.
M6P Therapeutics is headquartered in United States.
M6P Therapeutics operates in the following industries: Biopharma, Biotechnology, Health Care, Life Sciences.
M6P Therapeutics has approximately 20 employees.
Top alternatives and competitors to M6P Therapeutics include Zystor, Lysoway Therapeutics, Orphazyme, Caraway Therapeutics, Inc., Polaryx Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
M6P Therapeutics and Zystor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors M6P Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy